A Phase 1b Study of TAK-700 in Postmenopausal Women With Hormone-receptor Positive Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Post Menopausal, Hormone Receptor Positive Breast Cancer
Interventions: DRUG: TAK700
Sponsor: University of Wisconsin, Madison
Collaborators: Millennium Pharmaceuticals, Inc.